Kliogest (Norethisterone Acetate, Estradiol)

Norethisterone acetate and estradiol, the active ingredient in Kliogest, is an estrogen‑progestogen combination presented as an oral tablet for contraceptive use. It works by preventing ovulation and stabilising the endometrium to provide reliable cycle control.

GNH USA supplies Kliogest as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Kliogest, an oral estrogen‑progestogen combination, is used in hormonal contraception to prevent pregnancy. - Contraception: prevents pregnancy by inhibiting ovulation and stabilising the endometrium. - Menstrual cycle regulation: reduces irregular bleeding and provides predictable cycles. - Acne treatment: decreases androgen‑driven acne by lowering circulating androgen levels.

Kliogest may cause a range of adverse reactions. Patients should be aware of both common and serious possibilities.

Common Side Effects: - Nausea - Headache - Breast tenderness - Weight gain - Mood changes - Spotting or breakthrough bleeding

Serious or Rare Side Effects: - Venous thromboembolism (deep‑vein thrombosis, pulmonary embolism) - Stroke or transient ischemic attack - Myocardial infarction - Severe hypertension - Hepatic adenoma or other liver disorders - Anaphylactic reaction or severe allergic response

Before prescribing Kliogest, clinicians should consider several safety factors. - Assess thrombotic risk: evaluate personal or family history of clotting disorders. - Avoid smoking: especially in women over 35 years of age. - Monitor blood pressure: check regularly during therapy. - Consider liver function: contraindicated in active liver disease. - Review medication interactions: especially enzyme‑inducing drugs. - Store at ambient temperature: keep below 25 °C, in the original pack, and protect from moisture.

Kliogest can interact with other medicines, altering its effectiveness or safety.

Major Interactions (Avoid): - Antiepileptic enzyme inducers (e.g., carbamazepine, phenytoin): reduce contraceptive efficacy. - Rifampin and rifabutin: decrease hormone levels, compromising protection. - Griseofulvin: lowers effectiveness of the hormonal components.

Moderate Interactions (Monitor Closely): - Certain antibiotics (e.g., tetracycline, metronidazole): may slightly reduce efficacy. - Antifungal azoles (e.g., ketoconazole): can increase hormone concentrations, raising side‑effect risk. - Herbal supplements such as St. John’s wort: may reduce contraceptive effectiveness.